The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.

Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

SOHO Italy 2020

2nd Annual Society of Hematological Oncology (SOHO) Italian Meeting
22–24 September 2020 | Rome, Italy

This analysis was published recently in @BloodJournal

A BIG thank you for the worlwide collaboration that made possible one of the largest MRD studies in myeloma #mmsm

https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2022016782/486677/MRD-dynamics-during-maintenance-for-improved/ https://twitter.com/VJHemOnc/status/1575380146521083906

VJHemOnc@VJHemOnc

🎥 @BrunoPaiva_UNAV discusses the results of a pooled analysis of the TOURMALINE-MM3 and MM4 trials at #IMS2022:

👉http://ow.ly/iHYt50KVQEy👈

@Myeloma_Society #MMsm #HemOnc #mmMRD #BloodCancerAwarenessMonth

We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:

🎥: http://ow.ly/GGiK50KVRjM

#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022

We had a great interview with Catherine Coombs of @UNC, who shared some insights into novel BTK inhibitors in CLL and future outlooks.

@SocietyofHemOnc #SOHO22 #HemOnc #LeuSM #CLLsm

#SOHO22 | Peter Valk (@ErasmusMC) discusses TP53-mutated AML and MDS, the prognostic value of FLT3-ITD residual disease in AML, and more.

Visit http://VJHemOnc.com for our interviews from this year's meeting!

#SOHO2022 #HemOnc #LeuSM #AMLsm #MDSsm

Load More...

SOHO Italy 2020

2nd Annual Society of Hematological Oncology (SOHO) Italian Meeting
22–24 September 2020 | Rome, Italy

The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.

Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

This analysis was published recently in @BloodJournal

A BIG thank you for the worlwide collaboration that made possible one of the largest MRD studies in myeloma #mmsm

https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2022016782/486677/MRD-dynamics-during-maintenance-for-improved/ https://twitter.com/VJHemOnc/status/1575380146521083906

VJHemOnc@VJHemOnc

🎥 @BrunoPaiva_UNAV discusses the results of a pooled analysis of the TOURMALINE-MM3 and MM4 trials at #IMS2022:

👉http://ow.ly/iHYt50KVQEy👈

@Myeloma_Society #MMsm #HemOnc #mmMRD #BloodCancerAwarenessMonth

We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:

🎥: http://ow.ly/GGiK50KVRjM

#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022

We had a great interview with Catherine Coombs of @UNC, who shared some insights into novel BTK inhibitors in CLL and future outlooks.

@SocietyofHemOnc #SOHO22 #HemOnc #LeuSM #CLLsm

#SOHO22 | Peter Valk (@ErasmusMC) discusses TP53-mutated AML and MDS, the prognostic value of FLT3-ITD residual disease in AML, and more.

Visit http://VJHemOnc.com for our interviews from this year's meeting!

#SOHO2022 #HemOnc #LeuSM #AMLsm #MDSsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter